ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
71,140.90
-0.42%
S&P 500
5,308.13
0.09%
Dow Jones
39,806.77
-0.49%
US Dollar vs Yen
156.394
0.41%
Brent Oil
83.55
0.02%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Quanterix Corporation (QTRX)

  7. Quanterix Corporation (QTRX) ニュース

QTRX

Quanterix (QTRX)

Quanterix Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:QTRX
日付受信時刻ニュースソース見出しコード企業名
2024/05/1705 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
2024/05/1505 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
2024/05/0903 : 55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTRXQuanterix Corporation
2024/05/0805 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTRXQuanterix Corporation
2024/05/0805 : 00Business WireQuanterix Releases Financial Results for the First Quarter of 2024NASDAQ:QTRXQuanterix Corporation
2024/04/3005 : 00Business WireQuanterix To Report First Quarter 2024 Financial ResultsNASDAQ:QTRXQuanterix Corporation
2024/03/2206 : 30Business WireQuanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing InfrastructureNASDAQ:QTRXQuanterix Corporation
2024/03/0507 : 27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:QTRXQuanterix Corporation
2024/03/0506 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
2024/03/0423 : 00Business WireQuanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
2024/03/0106 : 58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:QTRXQuanterix Corporation
2024/03/0106 : 00Business WireQuanterix Releases Operating Results for Fourth Quarter and Full Year 2023NASDAQ:QTRXQuanterix Corporation
2024/02/2708 : 58Business WireQuanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 GuidanceNASDAQ:QTRXQuanterix Corporation
2024/02/2623 : 00Business WireQuanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
2024/02/2406 : 30Business WireQuanterix to Present at Cowen’s 44th Annual Health Care ConferenceNASDAQ:QTRXQuanterix Corporation
2024/02/1706 : 00Business WireQuanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference CallNASDAQ:QTRXQuanterix Corporation
2024/02/1607 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
2024/02/1506 : 57Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:QTRXQuanterix Corporation
2024/02/1506 : 38Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:QTRXQuanterix Corporation
2024/02/0706 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
2024/02/0706 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
2024/02/0206 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
2024/01/3106 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTRXQuanterix Corporation
2024/01/0506 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
2024/01/0506 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
2024/01/0406 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
2024/01/0307 : 21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:QTRXQuanterix Corporation
2023/12/1306 : 00Business WireQuanterix to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:QTRXQuanterix Corporation
2023/12/0206 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
2023/11/1406 : 00Business WireQuanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:QTRXQuanterix Corporation
 Showing the most relevant articles for your search:NASDAQ:QTRX

最近閲覧した銘柄

USOTC
RHHBY
Roche (QX)
FX
USDJPY
US Dollar vs Yen
CCOM
US30
US 30
FX
USDGBP
US Dollar vs Sterling
NYSE
CVX
Chevron
NYSE
MCD
McDonalds
NASDAQ
TSLA
Tesla
NASDAQ
NVDA
NVIDIA
NASDAQ
GOOGL
Alphabet
NYSE
VZ
Verizon Communications
COIN
SOLUSD
Solana
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有